Share
Seeger Weiss is proud to announce that partner Chris Ayers has been honored with the 2025 Section on Litigation Outstanding Practitioner Award by the Association of American Law Schools (AALS). This prestigious award recognizes attorneys who have demonstrated exceptional achievement and leadership in the practice of litigation at a national level.
The award, presented by AALS, not only highlights practical legal skills but also values a practitioner’s ability to contribute to the understanding and analysis of litigation issues through scholarship. Chris was selected for this distinguished honor based on his exemplary career advocating for clients in complex litigation matters and his impactful thought leadership within the legal community.
Chris has played key roles in major multidistrict litigations and class actions. Most notably, he represents the Estate of Henrietta Lacks, seeking justice against pharmaceutical and biotechnology companies profiting off Mrs. Lacks’s stolen cells for decades without her family’s consent. He played a key role in securing a historical settlement for unjust profits made from Mrs. Lacks’s stolen cells and is currently representing the Estate in lawsuits against Ultragenyx, Novartis, and Viatris Inc. in the United States District Court for the District of Maryland.
Chris represents individual and corporate plaintiffs in state and federal courts across the country. His practice focuses on class action, mass tort, and complex commercial litigation involving consumer protection, investment fraud, antitrust, whistleblower claims, product liability, and pharmaceutical injury. Recognized in e-discovery and preservation of electronically store information, Chris has served as designated ESI counsel in numerous high-profile cases.
Chris’s dedication to justice and his innovative approach to complex litigation have earned him this well-deserved recognition. We are thrilled to celebrate his ongoing success and look forward to his continued impact on behalf of Seeger Weiss clients. Prior results do not guarantee or predict a similar outcome in any future matter. The selection methodology for this award can be found here. No aspect of this or any advertisement has been approved by the Supreme Court of New Jersey.